AVTXAvalo Therapeutics, Inc.
- Market cap
- $371.66M
- as of 2026-10-23
- Latest close
- $6.93
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-12-21
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Lind Kevin Robert | Sep 30 | Oct 2 | A · derivative | 1,352 | $12.29 | $16,616 | 1,352 | No | Form 4 |
| Jain Rita | Sep 30 | Oct 2 | A · derivative | 1,322 | $12.29 | $16,247 | 1,322 | No | Form 4 |
| Philip Ron M | Sep 30 | Oct 2 | A · derivative | 1,109 | $12.29 | $13,630 | 1,109 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Sep 16 | Sep 18 | M | 12,394 | $9.88 | $122,453 | 52,294 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Sep 16 | Sep 18 | S | 12,394 | $16.33 | Sale −$202,394 | 39,900 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Sep 16 | Sep 18 | M · derivative | 12,394 | $9.88 | $122,453 | 83,848 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Sep 10 | Sep 11 | M | 10,185 | $8.04 | $81,887 | 50,085 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Sep 10 | Sep 11 | S | 10,185 | $17.62 | Sale −$179,460 | 39,900 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Sep 10 | Sep 11 | M · derivative | 10,185 | $8.04 | $81,887 | 105,815 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Aug 28 | Sep 1 | M | 679 | $8.04 | $5,459 | 52,455 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Aug 28 | Sep 1 | S | 679 | $20.00 | Sale −$13,580 | 51,776 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Aug 28 | Sep 1 | M · derivative | 679 | $8.04 | $5,459 | 113,734 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Aug 18 | Aug 19 | M | 31,031 | $9.88 | $306,586 | 70,931 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Aug 18 | Aug 19 | S | 31,031 | $20.05 | Sale −$622,172 | 39,900 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Aug 18 | Aug 19 | M · derivative | 31,031 | $9.88 | $306,586 | 96,242 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Aug 17 | Aug 19 | M | 37,945 | $9.88 | $374,897 | 78,718 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Aug 17 | Aug 19 | M | 2,876 | $9.88 | $28,415 | 81,594 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Aug 17 | Aug 19 | S | 37,945 | $19.85 | Sale −$753,208 | 43,649 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Aug 17 | Aug 19 | S | 3,749 | $19.94 | Sale −$74,755 | 39,900 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Aug 17 | Aug 19 | M · derivative | 37,945 | $9.88 | $374,897 | 130,149 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Aug 17 | Aug 19 | M · derivative | 2,876 | $9.88 | $28,415 | 127,273 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Aug 17 | Aug 19 | M | 1,000 | $12.65 | $12,650 | 52,776 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Aug 17 | Aug 19 | S | 1,000 | $20.00 | Sale −$20,000 | 51,776 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Aug 17 | Aug 19 | M · derivative | 1,000 | $12.65 | $12,650 | 123,750 | Yes | Form 4 |
| Riley JenniferChief Strategy Officer | Aug 11 | Aug 12 | S | 2,655 | $19.59 | Sale −$52,011 | 37,041 | No | Form 4 |
| Doyle MittieChief Medical Officer | Aug 10 | Aug 12 | M | 679 | $8.04 | $5,459 | 52,455 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Aug 10 | Aug 12 | S | 679 | $20.00 | Sale −$13,580 | 51,776 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Aug 10 | Aug 12 | M · derivative | 679 | $8.04 | $5,459 | 114,413 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Jul 27 | Jul 29 | M | 1,000 | $12.65 | $12,650 | 52,776 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Jul 27 | Jul 29 | S | 1,000 | $20.00 | Sale −$20,000 | 51,776 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Jul 27 | Jul 29 | M · derivative | 1,000 | $12.65 | $12,650 | 124,750 | Yes | Form 4 |
| Lind Kevin Robert | Jun 30 | Jul 2 | A · derivative | 1,105 | $15.04 | $16,619 | 1,105 | No | Form 4 |
| Jain Rita | Jun 30 | Jul 2 | A · derivative | 1,080 | $15.04 | $16,243 | 1,080 | No | Form 4 |
| Doyle MittieChief Medical Officer | Jun 30 | Jul 2 | M | 2,875 | $12.65 | $36,369 | 54,651 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Jun 30 | Jul 2 | M | 1,779 | $8.04 | $14,303 | 56,430 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Jun 30 | Jul 2 | S | 4,654 | $20.00 | Sale −$93,080 | 51,776 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Jun 30 | Jul 2 | M · derivative | 2,875 | $12.65 | $36,369 | 125,750 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Jun 30 | Jul 2 | M · derivative | 1,779 | $8.04 | $14,303 | 115,092 | Yes | Form 4 |
| Philip Ron M | Jun 30 | Jul 2 | A · derivative | 69 | $15.04 | $1,038 | 69 | No | Form 4 |
| Doyle MittieChief Medical Officer | Jun 23 | Jun 25 | M | 1,450 | $8.04 | $11,658 | 53,226 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Jun 23 | Jun 25 | S | 1,450 | $18.00 | Sale −$26,100 | 51,776 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Jun 23 | Jun 25 | M · derivative | 1,450 | $8.04 | $11,658 | 116,871 | Yes | Form 4 |
| Philip Ron M | Jun 23 | Jun 25 | A · derivative | 40,200 | $17.83 | $716,766 | 40,200 | No | Form 4 |
| Varki PaulChief Legal Officer | Jun 10 | Jun 12 | F | 1,081 | $13.10 | $14,161 | 32,576 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Jun 10 | Jun 12 | F | 138 | $13.10 | $1,808 | 40,773 | No | Form 4 |
| Doyle MittieChief Medical Officer | Jun 10 | Jun 12 | F | 1,084 | $13.10 | $14,200 | 51,776 | No | Form 4 |
| Riley JenniferChief Strategy Officer | Jun 10 | Jun 12 | F | 588 | $13.10 | $7,703 | 39,696 | No | Form 4 |
| Kaplan Gilla | Jun 2 | Jun 4 | A · derivative | 20,100 | $13.96 | $280,596 | 20,100 | No | Form 4 |
| Heffernan Michael Thomas | Jun 2 | Jun 4 | A · derivative | 29,500 | $13.96 | $411,820 | 29,500 | No | Form 4 |
| Lind Kevin Robert | Jun 2 | Jun 4 | A · derivative | 20,100 | $13.96 | $280,596 | 20,100 | No | Form 4 |
| Jain Rita | Jun 2 | Jun 4 | A · derivative | 20,100 | $13.96 | $280,596 | 20,100 | No | Form 4 |
| Kantoff Aaron | Jun 2 | Jun 4 | A · derivative | 20,100 | $13.96 | $280,596 | 20,100 | No | Form 4 |
| Truex Samantha | Jun 2 | Jun 4 | A · derivative | 20,100 | $13.96 | $280,596 | 20,100 | No | Form 4 |
| Doyle MittieChief Medical Officer | May 28 | Jun 1 | M | 679 | $8.04 | $5,459 | 47,801 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 28 | Jun 1 | S | 679 | $16.00 | Sale −$10,864 | 47,122 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 28 | Jun 1 | M · derivative | 679 | $8.04 | $5,459 | 118,321 | Yes | Form 4 |
| Neil Garry ArthurChief Executive Officer | May 21 | May 26 | A | 100,200 | $0.00 | $0 | 190,314 | No | Form 4 |
| Varki PaulChief Legal Officer | May 21 | May 26 | A | 24,300 | $0.00 | $0 | 27,934 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | May 21 | May 26 | A | 39,900 | $0.00 | $0 | 40,323 | No | Form 4 |
| Doyle MittieChief Medical Officer | May 21 | May 26 | A | 43,500 | $0.00 | $0 | 47,122 | No | Form 4 |
| Riley JenniferChief Strategy Officer | May 21 | May 26 | A | 34,200 | $0.00 | $0 | 36,855 | No | Form 4 |
| Doyle MittieChief Medical Officer | May 15 | May 19 | M | 3,000 | $12.65 | $37,950 | 6,622 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 15 | May 19 | S | 3,000 | $18.76 | Sale −$56,280 | 3,622 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 15 | May 19 | M · derivative | 3,000 | $12.65 | $37,950 | 128,625 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | May 7 | May 11 | M | 18,606 | $9.88 | $183,827 | 19,029 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | May 7 | May 11 | S | 18,606 | $24.12 | Sale −$448,777 | 423 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | May 7 | May 11 | M · derivative | 18,606 | $9.88 | $183,827 | 168,094 | Yes | Form 4 |
| Varki PaulChief Legal Officer | May 6 | May 7 | M | 62,500 | $13.43 | $839,375 | 66,134 | Yes | Form 4 |
| Varki PaulChief Legal Officer | May 6 | May 7 | M | 12,563 | $8.04 | $101,007 | 78,697 | Yes | Form 4 |
| Varki PaulChief Legal Officer | May 6 | May 7 | S | 37,375 | $18.91 | Sale −$706,761 | 41,322 | Yes | Form 4 |
| Varki PaulChief Legal Officer | May 6 | May 7 | S | 5,196 | $19.78 | Sale −$102,777 | 36,126 | Yes | Form 4 |
| Varki PaulChief Legal Officer | May 6 | May 7 | S | 22,839 | $21.22 | Sale −$484,644 | 13,287 | Yes | Form 4 |
| Varki PaulChief Legal Officer | May 6 | May 7 | S | 9,253 | $22.70 | Sale −$210,043 | 4,034 | Yes | Form 4 |
| Varki PaulChief Legal Officer | May 6 | May 7 | S | 400 | $23.71 | Sale −$9,484 | 3,634 | Yes | Form 4 |
| Varki PaulChief Legal Officer | May 6 | May 7 | M · derivative | 62,500 | $13.43 | $839,375 | 87,500 | Yes | Form 4 |
| Varki PaulChief Legal Officer | May 6 | May 7 | M · derivative | 12,563 | $8.04 | $101,007 | 87,437 | Yes | Form 4 |
| Chan Mitchell | May 6 | May 7 | S | 3,167 | $22.88 | Sale −$72,461 | 3,166 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | May 6 | May 7 | M | 47,000 | $8.04 | $377,880 | 47,423 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | May 6 | May 7 | S | 13,834 | $18.55 | Sale −$256,621 | 33,589 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | May 6 | May 7 | S | 12,347 | $19.28 | Sale −$238,050 | 21,242 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | May 6 | May 7 | S | 2,700 | $20.76 | Sale −$56,052 | 18,542 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | May 6 | May 7 | S | 9,219 | $21.37 | Sale −$197,010 | 9,323 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | May 6 | May 7 | S | 8,900 | $22.57 | Sale −$200,873 | 423 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | May 6 | May 7 | M · derivative | 47,000 | $8.04 | $377,880 | 116,000 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 6 | May 7 | M | 77,905 | $12.65 | $985,498 | 81,527 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 6 | May 7 | M | 28,650 | $8.04 | $230,346 | 110,177 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 6 | May 7 | S | 27,538 | $18.03 | Sale −$496,510 | 82,639 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 6 | May 7 | S | 5,000 | $19.65 | Sale −$98,250 | 77,639 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 6 | May 7 | S | 44,944 | $21.20 | Sale −$952,813 | 32,695 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 6 | May 7 | S | 19,015 | $22.41 | Sale −$426,126 | 13,680 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 6 | May 7 | S | 10,058 | $22.88 | Sale −$230,127 | 3,622 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 6 | May 7 | M · derivative | 77,905 | $12.65 | $985,498 | 131,625 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 6 | May 7 | M · derivative | 28,650 | $8.04 | $230,346 | 119,000 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 5 | May 7 | M | 1,000 | $12.65 | $12,650 | 4,622 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 5 | May 7 | M | 679 | $8.04 | $5,459 | 5,301 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 5 | May 7 | S | 1,679 | $16.00 | Sale −$26,864 | 3,622 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 5 | May 7 | M · derivative | 1,000 | $12.65 | $12,650 | 209,530 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | May 5 | May 7 | M · derivative | 679 | $8.04 | $5,459 | 147,650 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Apr 30 | May 1 | S | 8,457 | $13.23 | Sale −$111,886 | 423 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Apr 29 | May 1 | S | 8,458 | $13.09 | Sale −$110,715 | 8,880 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Apr 6 | Apr 8 | M | 3,970 | $12.65 | $50,221 | 7,592 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Apr 6 | Apr 8 | S | 3,970 | $18.01 | Sale −$71,500 | 3,622 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Apr 6 | Apr 8 | M · derivative | 3,970 | $12.65 | $50,221 | 210,530 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Apr 2 | Apr 3 | S | 6,200 | $17.02 | Sale −$105,524 | 19,118 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Apr 2 | Apr 3 | S | 1,780 | $17.57 | Sale −$31,275 | 17,338 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Apr 1 | Apr 3 | S | 500 | $15.86 | Sale −$7,930 | 32,797 | Yes | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Apr 1 | Apr 3 | S | 7,479 | $16.83 | Sale −$125,872 | 25,318 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Apr 1 | Apr 3 | M | 679 | $8.04 | $5,459 | 4,301 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Apr 1 | Apr 3 | S | 679 | $16.00 | Sale −$10,864 | 3,622 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Apr 1 | Apr 3 | M · derivative | 679 | $8.04 | $5,459 | 148,329 | Yes | Form 4 |
| Lind Kevin Robert | Mar 31 | Apr 1 | A · derivative | 1,370 | $12.13 | $16,618 | 1,370 | No | Form 4 |
| Jain Rita | Mar 31 | Apr 1 | A · derivative | 1,339 | $12.13 | $16,242 | 1,339 | No | Form 4 |
| Kaplan Gilla | Mar 28 | Mar 31 | M | 3,166 | not reported | not reported | 6,333 | No | Form 4 |
| Kaplan Gilla | Mar 28 | Mar 31 | M · derivative | 3,166 | $0.00 | $0 | 3,167 | No | Form 4 |
| Neil Garry ArthurChief Executive Officer | Mar 28 | Mar 31 | M | 64,866 | not reported | not reported | 112,006 | No | Form 4 |
| Neil Garry ArthurChief Executive Officer | Mar 28 | Mar 31 | F | 21,892 | $13.89 | $304,080 | 90,114 | No | Form 4 |
| Neil Garry ArthurChief Executive Officer | Mar 28 | Mar 31 | M · derivative | 64,866 | $0.00 | $0 | 64,867 | No | Form 4 |
| Chan Mitchell | Mar 28 | Mar 31 | M | 3,166 | not reported | not reported | 6,333 | No | Form 4 |
| Chan Mitchell | Mar 28 | Mar 31 | M · derivative | 3,166 | $0.00 | $0 | 3,167 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Mar 28 | Mar 31 | M | 24,200 | not reported | not reported | 41,538 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Mar 28 | Mar 31 | F | 8,241 | $13.89 | $114,467 | 33,297 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Mar 28 | Mar 31 | M · derivative | 24,200 | $0.00 | $0 | 24,200 | No | Form 4 |
| Kantoff Aaron | Mar 28 | Mar 31 | M | 3,166 | not reported | not reported | 6,333 | No | Form 4 |
| Kantoff Aaron | Mar 28 | Mar 31 | M · derivative | 3,166 | $0.00 | $0 | 3,167 | No | Form 4 |
| Goldman Jonathan | Mar 28 | Mar 31 | M | 3,166 | not reported | not reported | 3,166 | No | Form 4 |
| Goldman Jonathan | Mar 28 | Mar 31 | M · derivative | 3,166 | $0.00 | $0 | 3,167 | No | Form 4 |
| Truex Samantha | Mar 28 | Mar 31 | M | 3,166 | not reported | not reported | 6,333 | No | Form 4 |
| Truex Samantha | Mar 28 | Mar 31 | M · derivative | 3,166 | $0.00 | $0 | 3,167 | No | Form 4 |
| Doyle MittieChief Medical Officer | Mar 16 | Mar 18 | M | 19,500 | $12.65 | $246,675 | 23,122 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Mar 16 | Mar 18 | M | 5,992 | $8.04 | $48,176 | 29,114 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Mar 16 | Mar 18 | S | 25,492 | $16.15 | Sale −$411,696 | 3,622 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Mar 16 | Mar 18 | M · derivative | 19,500 | $12.65 | $246,675 | 214,500 | Yes | Form 4 |
| Doyle MittieChief Medical Officer | Mar 16 | Mar 18 | M · derivative | 5,992 | $8.04 | $48,176 | 149,008 | Yes | Form 4 |
| Neil Garry ArthurChief Executive Officer | Feb 26 | Mar 2 | A · derivative | 286,000 | $17.64 | $5,045,040 | 286,000 | No | Form 4 |
| Varki PaulChief Legal Officer | Feb 26 | Mar 2 | A · derivative | 80,000 | $17.64 | $1,411,200 | 80,000 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Feb 26 | Mar 2 | A · derivative | 105,000 | $17.64 | $1,852,200 | 105,000 | No | Form 4 |
| Doyle MittieChief Medical Officer | Feb 26 | Mar 2 | A · derivative | 105,000 | $17.64 | $1,852,200 | 105,000 | No | Form 4 |
| Riley JenniferChief Strategy Officer | Feb 26 | Mar 2 | A · derivative | 95,000 | $17.64 | $1,675,800 | 95,000 | No | Form 4 |
| Boyd TaylorChief Business Officer | Feb 26 | Mar 2 | A · derivative | 95,000 | $17.64 | $1,675,800 | 95,000 | No | Form 4 |
| Jain Rita | Dec 31, 2025 | Jan 5 | A · derivative | 1,043 | $14.74 | $15,374 | 1,043 | No | Form 4 |
| Lind Kevin Robert | Dec 31, 2025 | Jan 5 | A · derivative | 848 | $14.74 | $12,500 | 848 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Dec 10, 2025 | Dec 12, 2025 | F | 155 | $4.10 | $636 | 17,338 | No | Form 4 |
| Varki PaulChief Legal Officer | Dec 10, 2025 | Dec 12, 2025 | F | 1,016 | $4.10 | $4,166 | 3,634 | No | Form 4 |
| Riley JenniferChief Strategy Officer | Dec 10, 2025 | Dec 12, 2025 | F | 637 | $4.10 | $2,612 | 2,655 | No | Form 4 |
| Doyle MittieChief Medical Officer | Dec 10, 2025 | Dec 12, 2025 | F | 1,013 | $4.10 | $4,153 | 3,622 | No | Form 4 |
| Goldman Jonathan | Nov 14, 2025 | Nov 17, 2025 | S | 3,167 | $14.30 | Sale −$45,288 | not reported | No | Form 4 |
| Goldman Jonathan | Nov 14, 2025 | Nov 17, 2025 | M | 8,200 | $9.88 | $81,016 | 8,200 | No | Form 4 |
| Goldman Jonathan | Nov 14, 2025 | Nov 17, 2025 | S | 8,200 | $14.35 | Sale −$117,670 | not reported | No | Form 4 |
| Goldman Jonathan | Nov 14, 2025 | Nov 17, 2025 | M · derivative | 8,200 | $9.88 | $81,016 | 16,400 | No | Form 4 |
| Boyd TaylorChief Business Officer | Oct 1, 2025 | Oct 6, 2025 | A · derivative | 275,000 | $12.96 | $3,564,000 | 275,000 | No | Form 4 |
| Lind Kevin Robert | Oct 1, 2025 | Oct 2, 2025 | A · derivative | 40,200 | $12.96 | $520,992 | 40,200 | No | Form 4 |
| Jain Rita | Sep 30, 2025 | Oct 2, 2025 | A · derivative | 1,572 | $12.71 | $19,980 | 1,572 | No | Form 4 |
| Jain Rita | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 40,200 | $4.47 | $179,694 | 40,200 | No | Form 4 |
| Almenoff June Sherie | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 20,100 | $4.47 | $89,847 | 20,100 | No | Form 4 |
| Heffernan Michael Thomas | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 29,500 | $4.47 | $131,865 | 29,500 | No | Form 4 |
| Kantoff Aaron | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 20,100 | $4.47 | $89,847 | 20,100 | No | Form 4 |
| Kaplan Gilla | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 20,100 | $4.47 | $89,847 | 20,100 | No | Form 4 |
| Goldman Jonathan | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 20,100 | $4.47 | $89,847 | 20,100 | No | Form 4 |
| Chan Mitchell | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 20,100 | $4.47 | $89,847 | 20,100 | No | Form 4 |
| Truex Samantha | Jun 17, 2025 | Jun 18, 2025 | A · derivative | 20,100 | $4.47 | $89,847 | 20,100 | No | Form 4 |
| Neil Garry ArthurChief Executive Officer | Mar 28, 2025 | Apr 1, 2025 | M | 64,867 | not reported | not reported | 64,927 | No | Form 4 |
| Neil Garry ArthurChief Executive Officer | Mar 28, 2025 | Apr 1, 2025 | F | 17,787 | $8.46 | $150,478 | 47,140 | No | Form 4 |
| Neil Garry ArthurChief Executive Officer | Mar 28, 2025 | Apr 1, 2025 | M · derivative | 64,867 | $0.00 | $0 | 129,733 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Mar 28, 2025 | Apr 1, 2025 | M | 24,200 | not reported | not reported | 24,206 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Mar 28, 2025 | Apr 1, 2025 | F | 7,285 | $8.46 | $61,631 | 16,921 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Mar 28, 2025 | Apr 1, 2025 | M · derivative | 24,200 | $0.00 | $0 | 48,400 | No | Form 4 |
| Almenoff June Sherie | Mar 28, 2025 | Apr 1, 2025 | M | 3,167 | not reported | not reported | 3,167 | No | Form 4 |
| Almenoff June Sherie | Mar 28, 2025 | Apr 1, 2025 | M · derivative | 3,167 | $0.00 | $0 | 6,333 | No | Form 4 |
| Kaplan Gilla | Mar 28, 2025 | Apr 1, 2025 | M | 3,167 | not reported | not reported | 3,167 | No | Form 4 |
| Kaplan Gilla | Mar 28, 2025 | Apr 1, 2025 | M · derivative | 3,167 | $0.00 | $0 | 6,333 | No | Form 4 |
| Kantoff Aaron | Mar 28, 2025 | Apr 1, 2025 | M | 3,167 | not reported | not reported | 3,167 | No | Form 4 |
| Kantoff Aaron | Mar 28, 2025 | Apr 1, 2025 | M · derivative | 3,167 | $0.00 | $0 | 6,333 | No | Form 4 |
| Truex Samantha | Mar 28, 2025 | Apr 1, 2025 | M | 3,167 | not reported | not reported | 3,167 | No | Form 4 |
| Truex Samantha | Mar 28, 2025 | Apr 1, 2025 | M · derivative | 3,167 | $0.00 | $0 | 6,333 | No | Form 4 |
| Goldman Jonathan | Mar 28, 2025 | Apr 1, 2025 | M | 3,167 | not reported | not reported | 3,167 | No | Form 4 |
| Goldman Jonathan | Mar 28, 2025 | Apr 1, 2025 | M · derivative | 3,167 | $0.00 | $0 | 6,333 | No | Form 4 |
| Chan Mitchell | Mar 28, 2025 | Apr 1, 2025 | M | 3,167 | not reported | not reported | 3,167 | No | Form 4 |
| Chan Mitchell | Mar 28, 2025 | Apr 1, 2025 | M · derivative | 3,167 | $0.00 | $0 | 6,333 | No | Form 4 |
| Heffernan Michael Thomas | Mar 25, 2025 | Mar 26, 2025 | A · derivative | 50,000 | $8.54 | $427,000 | 50,000 | No | Form 4 |
| Doyle MittieChief Medical Officer | Jan 28, 2025 | Jan 30, 2025 | A · derivative | 155,000 | $8.04 | $1,246,200 | 155,000 | No | Form 4 |
| Neil Garry ArthurCEO and Chairman of the Board | Jan 28, 2025 | Jan 30, 2025 | A · derivative | 411,000 | $8.04 | $3,304,440 | 411,000 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Jan 28, 2025 | Jan 30, 2025 | A · derivative | 163,000 | $8.04 | $1,310,520 | 163,000 | No | Form 4 |
| Varki PaulChief Legal Officer | Jan 28, 2025 | Jan 30, 2025 | A · derivative | 100,000 | $8.04 | $804,000 | 100,000 | No | Form 4 |
| Riley JenniferChief Strategy Officer | Jan 1, 2025 | Jan 3, 2025 | A · derivative | 150,000 | $7.43 | $1,114,500 | 150,000 | No | Form 4 |
| Almenoff June Sherie | Nov 13, 2024 | Nov 14, 2024 | P | 500 | $13.00 | Purchase +$6,500 | 1,000 | No | Form 4 |
| Almenoff June Sherie | Nov 12, 2024 | Nov 14, 2024 | P | 500 | $12.50 | Purchase +$6,250 | 500 | No | Form 4 |
| Neil Garry ArthurCEO and Chairman of the Board | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 500,400 | $9.88 | $4,943,952 | 500,400 | No | Form 4 |
| Neil Garry ArthurCEO and Chairman of the Board | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 194,600 | $0.00 | $0 | 194,600 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 186,700 | $9.88 | $1,844,596 | 186,700 | No | Form 4 |
| Sullivan Christopher RyanChief Financial Officer | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 72,600 | $0.00 | $0 | 72,600 | No | Form 4 |
| Kaplan Gilla | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 24,600 | $9.88 | $243,048 | 24,600 | No | Form 4 |
| Kaplan Gilla | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 9,500 | $0.00 | $0 | 9,500 | No | Form 4 |
| Truex Samantha | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 24,600 | $9.88 | $243,048 | 24,600 | No | Form 4 |
| Truex Samantha | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 9,500 | $0.00 | $0 | 9,500 | No | Form 4 |
| Kantoff Aaron | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 24,600 | $9.88 | $243,048 | 24,600 | No | Form 4 |
| Kantoff Aaron | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 9,500 | $0.00 | $0 | 9,500 | No | Form 4 |
| Almenoff June Sherie | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 24,600 | $9.88 | $243,048 | 24,600 | No | Form 4 |
| Almenoff June Sherie | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 9,500 | $0.00 | $0 | 9,500 | No | Form 4 |
| Chan Mitchell | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 24,600 | $9.88 | $243,048 | 24,600 | No | Form 4 |
| Chan Mitchell | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 9,500 | $0.00 | $0 | 9,500 | No | Form 4 |
| Goldman Jonathan | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 24,600 | $9.88 | $243,048 | 24,600 | No | Form 4 |
| Goldman Jonathan | Aug 13, 2024 | Aug 14, 2024 | A · derivative | 9,500 | $0.00 | $0 | 9,500 | No | Form 4 |
| Doyle MittieChief Medical Officer | Jul 15, 2024 | Jul 16, 2024 | A · derivative | 234,000 | $12.65 | $2,960,100 | 234,000 | No | Form 4 |
| Varki PaulChief Legal Officer | Jun 24, 2024 | Jun 25, 2024 | A · derivative | 150,000 | $13.43 | $2,014,500 | 150,000 | No | Form 4 |
| Chan Mitchell | Dec 20, 2023 | Dec 21, 2023 | A · derivative | 3,334 | $0.04 | $133 | 3,334 | No | Form 4 |
| Kaplan Gilla | Dec 20, 2023 | Dec 21, 2023 | A · derivative | 3,334 | $0.04 | $133 | 3,334 | No | Form 4 |
| Almenoff June Sherie | Dec 20, 2023 | Dec 21, 2023 | A · derivative | 3,334 | $0.04 | $133 | 3,334 | No | Form 4 |
| Persson Magnus | Dec 20, 2023 | Dec 21, 2023 | A · derivative | 3,334 | $0.04 | $133 | 3,334 | No | Form 4 |